Status:
UNKNOWN
Hayman's Haemostatic Suture to Treat Severe Post-partum Haemorrhage
Lead Sponsor:
Università degli Studi dell'Insubria
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18-40 years
Brief Summary
Post-partum haemorrhage continues to be a leading cause of maternal mortality and morbidity, accounting for more than 125 000 deaths per year across the world. Prompt diagnosis and effective action ar...
Detailed Description
Post-partum haemorrhage continues to be a leading cause of maternal mortality and morbidity, accounting for more than 125 000 deaths per year across the world. Prompt diagnosis and effective action ar...
Eligibility Criteria
Inclusion
- Women that had major Post-partum Haemorrhage, resistant to pharmacologic therapy, treated with Hayman's Haemostatic Suture.
Exclusion
- None.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03442491
Start Date
June 1 2022
End Date
February 1 2024
Last Update
September 30 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.